Showing results (501-510 of 563) with videos related to

Sort By:
Pageof 57
European Urology Oncology|March 4, 2023
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission TomographyClayton P Smith, James A Proudfoot, Paul C Boutros, et al.
The Journal of Physiology|January 15, 2021
Time-restricted feeding combined with aerobic exercise training can prevent weight gain and improve metabolic disorders in mice fed a high-fat dietRenan Fudoli Lins Vieira, Vitor Rosetto Muñoz, Rafael Lima Junqueira, et al.
Circulation. Cardiovascular Interventions|December 14, 2021
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial InfarctionStefan James, Sasha Koul, Jonas Andersson, et al.
European Urology|March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective StudyManuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
The Lancet. Oncology|June 3, 2023
Health-related quality of life and pain outcomes with [<sup>177</sup>Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trialKarim Fizazi, Ken Herrmann, Bernd J Krause, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II studyJean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancerM Namer, P Soler-Michel, F Turpin, et al.
The Lancet. Oncology|August 4, 2019
<sup>18</sup>F-fluciclovine PET-CT and <sup>68</sup>Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trialJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 6, 2023
Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysisJ D Subiela, E Gomis Sellés, A Maldonado, et al.
Journal of the American College of Cardiology|March 11, 2022
5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow ReserveMatthias Götberg, Karolina Berntorp, Rebecca Rylance, et al.
Pageof 57